Celldex 制药 CLDX
$29.87 +$1.60 (+5.66%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $30.00 +0.44%
开盘$27.85
昨收$28.27
当日区间$27.82 – $30.15
成交量926.3K
市值$2.35B
市盈率（TTM）–
股息率–
CLDX 相关新闻
匹配 Celldex Therapeutics 或代码 CLDX 的头条新闻，按最新排序。
- LifeSci Capital Maintains Celldex Therapeutics(CLDX.US) With Buy Rating, Raises Target Price to $64 正面
- Morgan Stanley Maintains Celldex Therapeutics(CLDX.US) With Buy Rating, Maintains Target Price $57
- A Quick Look at Today's Ratings for Celldex Therapeutics(CLDX.US), With a Forecast Between $50 to $88
- Leerink Partners Maintains Outperform on Celldex Therapeutics, Raises Price Target to $88 正面
- Celldex Therapeutics Is Maintained at Overweight by Morgan Stanley
- A Quick Look at Today's Ratings for Celldex Therapeutics(CLDX.US), With a Forecast Between $50 to $100
- Celldex Therapeutics Is Maintained at Outperform by Leerink Partners 正面
- Celldex Therapeutics Price Target Raised to $88.00/Share From $70.00 by Leerink Partners 正面
- Analysts' Opinions Are Mixed on These Healthcare Stocks: Owlet (OWLT), Celldex (CLDX) and Edgewise Therapeutics (EWTX)
- Celldex Therapeutics | 8-K: Current report
- LifeSci Capital Maintains Celldex Therapeutics(CLDX.US) With Buy Rating, Maintains Target Price $56
- Morgan Stanley Maintains Celldex Therapeutics(CLDX.US) With Buy Rating, Raises Target Price to $50 正面
- A Quick Look at Today's Ratings for Celldex Therapeutics(CLDX.US), With a Forecast Between $42 to $56
- 10-Q: Celldex Therapeutics | 10-Q: Q2 2026 Earnings Report
- A Quick Look at Today's Ratings for Celldex Therapeutics(CLDX.US), With a Forecast Between $42 to $100
暂无评论——快来第一个聊聊 CLDX。
登录后参与讨论。